Loading clinical trials...
Loading clinical trials...
The objective of this study is to understand if Rivaroxaban can improve treatment satisfaction of Warfarin patients and assess the safety and effectiveness of Xarelto in real clinical practice. A tot...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bayer
Collaborators
NCT05232643 · Non-Valvular Atrial Fibrillation (NVAF)
NCT06606275 · End-Stage Kidney Disease (ESKD), Non-valvular Atrial Fibrillation (NVAF), and more
NCT05022758 · Non-valvular Atrial Fibrillation (NVAF)
NCT02954237 · Non-valvular Atrial Fibrillation (NVAF)
Multiple Locations
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions